Olga Berdina

Dr. Olga Berdina


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2016 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
IMIrina Madaeva
Irina Madaeva
OBOlga Berdina
Olga Berdina
VPVladimir Polyakov
Vladimir Polyakov
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
Background. There are limited published data in regard to the relationship between obstructive sleep apnea (OSA) and hypertension and neurobehavioral and mental status in adolescence. The aim of our study was to evaluate neurobehavioral patterns and cognitive functions in adolescents with hypertension according to absence or presence of OSA.Methods. This was a retrospective cohort study completed at the Scientific Center for Family Health and Human Reproduction Problems. Participants included adolescents aged 14–17 years and referred for 24-hour ambulance blood pressure monitoring (ABPM) and polysomnographic (PSG) studies between 2007 and 2009, inclusive.Results. 18 hypertensive OSA (the 1st group) and 20 hypertensive non-OSA adolescents (the 2nd group) were included in the study. Significant changes of neurobehavioral functioning in OSA patients were shown. Cognitive abilities also were impaired. Verbal and visual memory indexes and attention index were 2.1 and 2.2 times lower, accordingly, in the 1st group than in the 2nd group (P<0.05). Speech index was significantly 2.8 times lower in OSA patients than in non-OSA patients (P<0.05). In hypertensive OSA adolescents more significant Spearman correlations between classic sleep parameters and cognitive measures were found compared to patients without OSA.Conclusions. These results suggest that OSA is closely associated with neurobehavioral and cognitive functioning in hypertensive adolescents.

26 April 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
OBOlga Berdina
Olga Berdina
IMIrina Madaeva
Irina Madaeva
SBSvetlana Bolshakova
Svetlana Bolshakova
LSLeonid Sholokhov
Leonid Sholokhov
LRLiubov Rychkova
Liubov Rychkova
Background and Objective: Obstructive sleep apnea (OSA) and obesity are associated with stress system activation involving the hypothalamic-pituitary-adrenal (HPA) axis in adults, but these effects in childhood and adolescence remain unclear. We examined diurnal salivary cortisol as a measurement of the HPA axis function in obese adolescents with and without OSA and the relationships between cortisol levels, body weight, and parameters of polysomnography (PSG).Methods: After PSG, saliva samples were collected from obese participants (with and without OSA) and lean participants four times over a 24-h period, namely, at 7:00 h (m-sCort), 13:00 h (a-sCort), 19:00 h (e-sCort), and 23:00 h (n-sCort). An enzyme-linked immunosorbent assay (ELISA) was used to measure salivary cortisol levels. The mean values of cortisol levels and fixed-time point diurnal cortisol slope (DCS) were calculated and compared among the three study groups. Correlations between parameters were analyzed using Spearman's correlation coefficients.Results: Obese OSA participants had significantly higher e-sCort and n-sCort levels than both obese non-OSA participants and lean controls. However, m-sCort and a-sCort in these patients had a pronounced upward trend. M-sCort was significantly correlated with both the lowest oxygen saturation (SpO2) and time with SpO2<90%. Moreover, in the obese OSA group, DCS was significantly flatter than in the other two groups. The a-sCort in obese non-OSA participants was significantly higher than that in the lean control group and, surprisingly, was positively correlated with the apnea/hypopnea index. Additionally, m-sCort was related to body weight.Conclusion: This study provided further evidence for alterations in diurnal cortisol production in obese adolescents, which may indicate a chronically stressed HPA axis. However, there were significant differences in salivary cortisol parameters between participants with and without OSA. Furthermore, patients with OSA had more associations between time-point cortisol levels and OSA-related indices. Nonetheless, this research is a pilot study, and further investigations are necessary.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
IMIrina Madaeva
Irina Madaeva
NKNadezhda Kurashova
Nadezhda Kurashova
EUE.B. Ukhinov
E.B. Ukhinov
OBOlga Berdina
Olga Berdina
NSNatalya Semenova
Natalya Semenova
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить относительную длину теломер (ОДТ) у пациентов с синдромом обструктивного апноэ (СОАС) до и после 6-месячного курса терапии созданием постоянного положительного давления воздуха в дыхательных путях (СИПАП-терапия). МАТЕРИАЛ И МЕТОДЫ В исследовании участвовали 75 мужчин, средний возраст 53,4±3,6 года. Основную группу (ОГ1) составили 50 мужчин с СОАС; полностью завершили исследование 35 мужчин — ОГ2. Контрольную группу (КГ) составили 25 мужчин без СОАС. Согласно дизайну исследования, всем была проведена ночная полисомнография (ПСГ); забор крови для оценки ОДТ осуществлялся утром по стандартной методике. Значения ОДТ получали, используя разницу между значениями пороговых циклов для теломерной ДНК и референсного гена альбумина (∆Ct). После уточнения диагноза была применена СИПАП-терапия в течение 6 мес. РЕЗУЛЬТАТЫ Выявлены статистически значимые показатели ПСГ: снижение глубоких стадий сна у пациентов с СОАС в сравнении с КГ (89,3±15,8 мин против 150±23,4 мин), увеличение поверхностных стадий при СОАС (296,2±31,1 и 170,1±24,5 мин соответственно), сокращение времени фазы быстрого сна (ФБС) (84,6±15,4 и 118,5±19,5 мин). Проведение в течение 6 мес постоянной СИПАП-терапии (не менее 4—5 ночей в 1 нед, длительностью не менее 5—6 ч ночного сна) положительно повлияло на качественные и количественные параметры сна. У лиц ОГ1 отмечалось укорочение ОДТ, по сравнению с мужчинами КГ (p<0,001). При устранении гипоксии и улучшении структуры сна после СИПАП-терапии отмечено увеличение показателя ОДТ в ОГ1 с 0,28 [0,24—0,29] до 0,32 [0,30—0,34] в ОГ2 (p=0,003). Медиана данного показателя в КГ составила 0,53 [0,50—0,55]. ЗАКЛЮЧЕНИЕ Интермиттирующая гипоксия и фрагментация сна при СОАС приводят к укорочению теломер. СИПАП-терапия, устраняя патофизиологические триггеры СОАС, способствует увеличению ОДТ в концевых участках хромосом и может замедлить преждевременное старение организма при СОАС.

8 June 2017 in Sleep and Biological Rhythms
Verified
Journal Article
Closed access
PDF file
IMIrina Madaeva
Irina Madaeva
OBOlga Berdina
Olga Berdina
LRLiubov Rychkova
Liubov Rychkova
OBOlga Bugun
Olga Bugun

20 October 2021 in Neurology and Therapy
Verified
Journal Article
Open access
PDF file
IMIrina Madaeva
Irina Madaeva
OBOlga Berdina
Olga Berdina
NKNadezhda Kurashova
Nadezhda Kurashova
NSNatalya Semenova
Natalya Semenova
EUErdem B. Ukhinov
Erdem B. Ukhinov
LKLyubov I. Kolesnikova
Lyubov I. Kolesnikova
Introduction The high prevalence of obstructive sleep apnea (OSA), which impairs quality of life for numerous patients and leads to various OSA complications, has contributed to the continued interest in this disorder. The role of serotonin (5-HT) in many physiological processes, studies on its connection with the circadian system, and relationship to changes in sleep architecture are insufficient to assess the interaction of this neurotransmitter with nocturnal hypoxia. The aim of this study was to determine changes in sleep patterns and serum serotonin levels before and after positive airway pressure (PAP) therapy in patients with OSA. Methods The study involved 30 OSA patients (27 men and 3 women) who were treated with PAP for 3 months. Polysomnography using the GRASS TELEFACTOR (USA) and blood collection were conducted before and after PAP courses. Determination of serum serotonin was performed by high-performance liquid chromatography (HPLC). PAP therapy was performed using an automatic Prisma 20A (Germany) continuous positive airway pressure (CPAP) device. Results The use of PAP for 3 months revealed a significant improvement as measured by sleep data and serotonin levels (before: apnea index [AI] 17.2 eV/h, after: 2.4 eV/h p = 0.001; SpO2 < 90% − 45.7 min vs. 6.2 min p = 0.001; serotonin 20.3 ng/mL vs. 26.03 ng/mL p = 0.036]. Conclusion Our results demonstrate an improvement in sleep patterns. There was an increase in serum serotonin levels in OSA patients following PAP therapy, which could be an effect of intermittent hypoxia decline, and could be used as criteria for the effectiveness of PAP and an improvement in sleep quality.

20 December 2023 in The European Physical Journal Special Topics
Verified
Journal Article
Closed access
PDF file
OBOlga Berdina
Olga Berdina
IMIrina Madaeva
Irina Madaeva
LRLiubov Rychkova
Liubov Rychkova